Can you take Alli with Wegovy at the same time?

Why would someone want to take both, and is the idea as straightforward as it sounds?

A common misconception is that two weight-loss medicines working by different mechanisms must be safe to stack. The logic feels intuitive: one reduces fat absorption, the other suppresses appetite, so surely both together would work harder. In practice, it is more complicated than that. Neither Wegovy nor Alli is licensed for use in combination with the other, and no clinical trial has established that the approach is effective or safe enough to recommend.

Wegovy works as a GLP-1 receptor agonist, slowing gastric emptying, increasing feelings of fullness and reducing calorie intake through appetite signalling. Orlistat works entirely differently: it inhibits pancreatic lipase in the gut, so around a third of the fat you eat passes through undigested. The pathways are separate, yes, but the gut is not. Both medicines can cause nausea, loose stools, diarrhoea and abdominal discomfort, particularly early in treatment or after a dose increase. Layering orlistat on top of an active semaglutide regimen risks compounding those effects in a way that is hard to predict and harder to manage.

The range of medicines that interact with semaglutide is broader than many people realise, which is exactly why your prescriber reviews your full medicine list before and during treatment.

Does orlistat interfere with how Wegovy is absorbed or how well it works?

Semaglutide in Wegovy is injected subcutaneously, so gut-level absorption is not the concern it would be with an oral medicine. That said, orlistat's effect on fat-soluble vitamin absorption is well established: vitamins A, D, E and K are all affected to some degree, and this matters on a calorie-restricted diet where dietary sources of those vitamins may already be lower. If you are taking any fat-soluble supplements or medicines alongside Wegovy, adding orlistat without telling your prescriber could quietly reduce their efficacy.

There is also the question of what happens to your tolerability. The full Wegovy treatment pathway involves a gradual dose escalation precisely because gastrointestinal side effects need time to settle at each stage. Orlistat, particularly if you eat any fat (which most people do), causes its own predictable GI effects. Running the two simultaneously during an active titration phase creates a muddled picture: if you feel unwell, neither your prescriber nor you can easily tell which medicine is responsible or whether a dose adjustment is needed.

The NHS guidance on weight-management injections is clear that prescribers should have a complete and accurate medicines list. If you are considering adding anything to your current regimen, that conversation should happen before you start, not after.

What should you actually do if Wegovy alone feels like it is not doing enough?

This is, genuinely, the question behind most queries like this one. If you are on Wegovy and feeling like progress has stalled, the answer is almost never to add an over-the-counter product independently. There are several legitimate clinical routes worth discussing with your prescriber first.

Dose titration may be the most relevant option. The standard Wegovy escalation runs from 0.25mg up to a 2.4mg maintenance dose, and the newer 7.2mg pen, approved by the MHRA in April 2026, is now available for eligible patients at the upper end of the schedule. Many people do not reach their full maintenance dose before concluding treatment is not working. A prescriber can review whether you are at your optimal dose, whether adherence to lifestyle changes is part of the picture, and whether your current plan suits you.

You can also look at the broader range of licensed weight-loss treatments to understand what options exist at different stages. What tends not to help is adding an over-the-counter medicine to a prescription treatment without telling anyone, it muddies the clinical picture and removes the safety net that clinical oversight provides.

How does a prescriber approach medicines you are already taking when you start Wegovy?

Before any prescription for Wegovy is issued, a full medicine review is part of the process. This is not bureaucracy; it is how drug interactions and overlapping side effects get caught before they become a problem. The list of medicines that need careful review alongside Wegovy includes everything from blood-pressure treatments to oral contraceptives, and a thorough assessment of your history is what makes a prescription safe to issue.

At nume, every consultation is read by a GPhC-registered Independent Prescriber on the day it arrives. A real clinician looks at your answers, not a queue for automated processing. If you are already using any weight-management product, including Alli, you would note that in your consultation and the prescriber would factor it into their decision. Semaglutide and its interactions with other medicines are covered in detail in guidance on what to avoid while taking Wegovy, and the NHS medicines information page for semaglutide is a reliable reference for the full side-effect and interaction profile as reviewed by the NHS clinical pharmacists who maintain it.

If you are weighing up whether Wegovy or another treatment fits your situation, a free consultation with our prescribers is the place to start. Context about what Wegovy treatment costs privately in the UK is on our prices page if that is useful background before you do.